Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Oral diltiazem carbomer may have beneficial effects in esophageal spasm

Dec. 1, 2000

Novel H3 receptor agonists show full agonist activity in vivo after oral dosing

Nov. 30, 2000

Imifuramine: synthesis of a novel histamine H3 receptor agonist

Nov. 30, 2000

All patients dosed in trial of long-acting inhaled formulation of albuterol for asthma

Nov. 30, 2000

Promising candidate for asthma, COPD therapy characterized by Pfizer researchers

Nov. 28, 2000

Roche's new antiinflammatory agents inhibit alpha4 integrin binding

Nov. 27, 2000

PDE4 inhibitor YM-976 is first to show dissociation between antiinflammatory activity and emesis

Nov. 23, 2000

Synthesis and use of new integrin antagonists in the therapy of asthma

Nov. 21, 2000

Initiation of phase II CF trial with tgAAV-CF announced

Nov. 21, 2000

FDA okays Discovery's phase II trial with Surfaxin

Nov. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...